Inspire Medical Systems (NYSE:INSP) Trading 5.4% Higher - Here's Why

Key Points

• Inspire Medical Systems shares rose 5.4% to about $65.51 in mid-day trading, although volume was 86% below the daily average.
• Analyst sentiment remains mixed: Zacks Research upgraded the stock to “strong buy,” while the broader analyst consensus is still “Hold” with an average price target of $66.19.
• The company exceeded quarterly expectations, reporting $0.14 in EPS versus an expected loss of $0.24 and revenue of $200.58 million versus $194.72 million expected, despite a 7.6% year-over-year revenue decline.

Inspire Medical Systems, Inc. (NYSE:INSP - Get Free Report) shares shot up 5.4% during mid-day trading on Wednesday . The company traded as high as $64.25 and last traded at $65.5080. Approximately 148,769 shares traded hands during trading, a decline of 86% from the average daily volume of 1,075,850 shares. The stock had previously closed at $62.14.

Wall Street Analyst Weigh In

INSP has been the subject of a number of recent analyst reports. Zacks Research raised shares of Inspire Medical Systems from a "hold" rating to a "strong-buy" rating in a research note on Monday, August 17th. Mizuho lifted their price objective on shares of Inspire Medical Systems from $55.00 to $65.00 and gave the company an "outperform" rating in a report on Tuesday, August 4th. Summit Redstone set a $39.00 target price on shares of Inspire Medical Systems in a research report on Friday, May 22nd. Oppenheimer raised shares of Inspire Medical Systems from a "market perform" rating to an "outperform" rating and set a $85.00 price target for the company in a research note on Tuesday, August 4th. Finally, Robert W. Baird boosted their price target on Inspire Medical Systems from $54.00 to $59.00 and gave the company a "neutral" rating in a report on Tuesday, August 4th. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating, eleven have issued a Hold rating and three have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Hold" and an average target price of $66.19.

Inspire Medical Systems Trading Up 5.0%

The company has a market cap of $1.89 billion, a PE ratio of 14.16, a P/E/G ratio of 4.79 and a beta of 0.70. The firm's 50-day simple moving average is $55.76 and its two-hundred day simple moving average is $52.40.

Inspire Medical Systems (NYSE:INSP - Get Free Report) last announced its quarterly earnings data on Monday, August 3rd. The company reported $0.14 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.24) by $0.38. The firm had revenue of $200.58 million during the quarter, compared to analysts' expectations of $194.72 million. Inspire Medical Systems had a return on equity of 8.64% and a net margin of 15.03%.The company's revenue for the quarter was down 7.6% compared to the same quarter last year. During the same period last year, the business posted $0.45 earnings per share. Inspire Medical Systems has set its FY 2026 guidance at 1.050-1.450 EPS. As a group, analysts predict that Inspire Medical Systems, Inc. will post 1.24 EPS for the current year.

Insiders Place Their Bets

In other news, insider Jason Kelly sold 963 shares of the company's stock in a transaction that occurred on Friday, August 7th. The stock was sold at an average price of $59.55, for a total transaction of $57,346.65. Following the completion of the transaction, the insider directly owned 18,985 shares of the company's stock, valued at $1,130,556.75. This represents a 4.83% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this link. Insiders own 2.20% of the company's stock.

Institutional Investors Weigh In On Inspire Medical Systems

A number of large investors have recently modified their holdings of the business. CWM LLC increased its stake in shares of Inspire Medical Systems by 216.1% in the 4th quarter. CWM LLC now owns 354 shares of the company's stock worth $33,000 after acquiring an additional 242 shares during the last quarter. EverSource Wealth Advisors LLC grew its holdings in shares of Inspire Medical Systems by 1,115.4% in the first quarter. EverSource Wealth Advisors LLC now owns 632 shares of the company's stock valued at $33,000 after purchasing an additional 580 shares during the period. Havemeyer Place LP acquired a new stake in Inspire Medical Systems during the fourth quarter worth about $39,000. Smartleaf Asset Management LLC increased its position in Inspire Medical Systems by 84.0% during the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company's stock worth $42,000 after purchasing an additional 205 shares during the last quarter. Finally, Versant Capital Management Inc raised its stake in Inspire Medical Systems by 379.0% during the second quarter. Versant Capital Management Inc now owns 958 shares of the company's stock worth $43,000 after purchasing an additional 758 shares during the period. Hedge funds and other institutional investors own 94.91% of the company's stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company's flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.